Press Releases :: Journey Medical Corporation (DERM)

Nov 12, 2021

Journey Medical Corporation Prices $35.2 Million Initial Public Offering

Nov 8, 2021

Journey Medical Corporation Announces Launch of its Initial Public Offering

Apr 5, 2021

Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank

Apr 1, 2021

Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA®

arrow_back
1
2
3
4
5

rss_feed News RSS